DailyFinance.com : Oncolytics Biotech Inc. (NASDAQ: ONCY) just reasserted its position on the map again. The company has announced test results showing tumor shrinkage data from its U.S. Phase II clinical trial in patients with squamous cell carcinoma of the lung. This ... Read more